Risky Women: Disrupting Simple Notions of Women's HIV Risk

In 2012, the FDA approved Truvada for PrEP use among adult women and men who are "at risk" of HIV infection in the U.S. But exactly which women are at risk, how such risk is defined and understood, and whether or not women see themselves in this way is not entirely clear. Speakers in this webinar will present what is known from social and behavioral science and community experience about the definitions and perceptions of HIV risk among women that are relevant to their potential PrEP use. The webinar is co-sponsored by SisterLove, Inc., AVAC, HIV Prevention Justice Alliance, National Women's Health Network and the Well Project.

(Please note: Your name and comment will be public, and may even show up in Internet search results. Be careful when providing personal information! Beforeadding your comment, please read TheBody.com's Comment Policy.)

The Body is a service of Remedy Health Media, LLC, 750 3rd Avenue, 6th Floor, New York, NY 10017. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.